# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-092257
Filing Date
2024-08-07
Accepted
2024-08-07 06:45:21
Documents
63
Period of Report
2024-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | cycn-20240630.htm iXBRL | 10-Q | 1427562
2 | EX-10.1 | cycn-ex10_1.htm | EX-10.1 | 63168
3 | EX-31.1 | cycn-ex31_1.htm | EX-31.1 | 11789
4 | EX-31.2 | cycn-ex31_2.htm | EX-31.2 | 11792
5 | EX-32.1 | cycn-ex32_1.htm | EX-32.1 | 6343
6 | EX-32.2 | cycn-ex32_2.htm | EX-32.2 | 6346
| Complete submission text file | 0000950170-24-092257.txt |  | 6391238

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | cycn-20240630.xsd | EX-101.SCH | 1074674
65 | EXTRACTED XBRL INSTANCE DOCUMENT | cycn-20240630_htm.xml | XML | 1046982

Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Filer) CIK: 0001755237 (see all company filings)

EIN.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38787 | Film No.: 241181335
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)